Would the original two major shareholders, having been an advantage at the outset, be disadvantages to financing? Would a major financing partner be concerned about Nyrstar's approximately 19.9%? Nyrstar hasn't funds to make a takeover offer. Would/could a major financing partner gain enough shares to dilute Nyrstar's (and our) holding? I'm unschooled so don't take my speculation as significant please. Would like views, thanks.
Greenland Day, page-13
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IBG (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.077M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $1.72K | 573.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 21717489 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 24688407 | 17 |
View Market Depth
| Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
| IBG (ASX) Chart |